Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Biotech Firm BioXcel Therapeutics Secures Future on Nasdaq After Meeting $35M Market Value Threshold

Summary by stocktitan.net
AI-driven biopharma company BioXcel Therapeutics (BTAI) successfully regains Nasdaq compliance by meeting $35M market value requirement. Panel review process concluded Sept 17.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

stocktitan.netstocktitan.net

Biotech Firm BioXcel Therapeutics Secures Future on Nasdaq After Meeting $35M Market Value Threshold

AI-driven biopharma company BioXcel Therapeutics (BTAI) successfully regains Nasdaq compliance by meeting $35M market value requirement. Panel review process concluded Sept 17.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Thursday, September 18, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Branford, Connecticut icon

Branford, Connecticut

News
For You
SearchBlindspotLocal